A two-stage design for a phase II clinical trial of coenzyme Q10 in ALS.

نویسندگان

  • G Levy
  • P Kaufmann
  • R Buchsbaum
  • J Montes
  • A Barsdorf
  • R Arbing
  • V Battista
  • X Zhou
  • H Mitsumoto
  • B Levin
  • J L P Thompson
چکیده

BACKGROUND The combination of a small pool of patients at any given time with the availability of many potential neuroprotective agents to be tested in ALS requires efficient phase II trial designs. OBJECTIVE To describe the design of the Clinical Trial of High Dose Coenzyme Q10 (CoQ10) in ALS (QALS study)--a phase II, randomized, placebo-controlled, double-blind, multicenter clinical trial. METHODS The study design features two stages. The first stage (dose selection) identifies which of two doses of CoQ10 (1800 mg or 2700 mg) is preferred using a selection procedure rather than a formal hypothesis test. The second stage (early efficacy test) compares the preferred dose of CoQ10 against placebo using a non-superiority or futility design. Data from patients assigned to the preferred dose of CoQ10 in the first stage are also used in the second stage. The primary outcome measure is the decline in Amyotrophic Lateral Sclerosis Functional Rating Scale-revised (ALSFRSr) score from baseline to 9 months. RESULTS The total sample size required is 185 patients, as compared to a much larger sample size estimated to be necessary using a conventional superiority design (total: 852 patients). The authors report a bias correction made necessary by the inclusion of patient data from the first stage in the second stage. CONCLUSIONS Several features of the Clinical Trial of High Dose Coenzyme Q10 in ALS study design promote efficiency. These features may be beneficial in phase II trials in amyotrophic lateral sclerosis and other fields.

برای دانلود رایگان متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Effects of Coenzyme Q10 Supplementation on Antioxidant Enzyme and Lipid peroxide Activities in Women with Multiple Sclerosis: a Randomized, Placebo-controlled Trial

Background and Objectives:Oxidative stress has been reported to provide neurodegeneration in multiple sclerosis (MS). Coenzyme Q10 is an endogenous lipid-soluble antioxidant. Up-to-date, no intervention studies have investigated coenzyme Q10 supplementation in MS. The purpose of this study was to investigate oxidative stress and antioxidant enzyme and lipid peroxide activities in women with MS...

متن کامل

اثر مکمل کوآنزیم Q10 بر فشارخون بیماران مبتلا به پرفشاری خون: یک مطالعه کارآزمایی بالینی تصادفی دو سو بی خبر

  Background : Hypertension is one of the most important challenges in human health and is now the most important risk factor for cardiovascular and renal diseases . Thus, using new approaches to manage and treat this problem is important . This study aimed to determine the effect of coenzyme-Q10 supplementation on blood pressure in hypertensive patients.   Methods : This randomized clinical tr...

متن کامل

Evaluation of the therapeutic effect of coenzyme Q10 in patients with generalized vitiligo

Background: Vitiligo is a skin autoimmune disease that affects 0.1% to more than 8% of people in the world. About 50% of patients develop the disease before the age of 20. In this disease, melanocytes are destroyed in the skin, mucous membranes and retina. As a result, white spots appear on different parts of the body. Studies have suggested the role of oxidative stress in vitiligo. Coenzyme Q1...

متن کامل

Effects of coenzyme Q10 on health-related quality of life, clinical disease activity and blood pressure in patients with mild to moderate ulcerative colitis: a randomized clinical trial

Background: Ulcerative colitis (UC) is specified by a chronic mucosal inflammation that has a deleterious impact on the quality of life (QoL). Coenzyme Q10 (CoQ10) appears to influence disease activity by its obvious properties. Therefore, the current research intends to assess the impacts of CoQ10 on QoL, disease activity, and blood pressure in UC patients.    Methods: This clinical trial per...

متن کامل

Comparison of the effect of Coenzyme Q10 and N-acetyl cysteine in prevention of acute kidney disease in critically ill patients admitted to Pediatric Intensive Care Unit

Background: Acute renal injury (AKI) is one of the most common causes of mortality in children admitted to intensive care units (PICU). Here, we investigated the preventive effect of N-acetylcysteine ​​(NAC) and Coenzyme Q10 on AKI among children admitted to PICU. Methods: This double-blind randomized clinical trial study was done on 78 children admitted to PICU in 2018. Patients were randomly...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

عنوان ژورنال:
  • Neurology

دوره 66 5  شماره 

صفحات  -

تاریخ انتشار 2006